Millhouse

BrainQ is a company founded in 2016 and headquartered in Jerusalem, Israel, that focuses on developing precision neurology therapies for individuals with neuro disorders. The company operates a neuro recovery platform that employs a brain-computer interface (BCI) approach to target damaged neuronal networks. By integrating machine learning algorithms with neuroscience, BrainQ extracts biological insights that inform the creation of tailored therapies. These innovations aim to facilitate neuro recovery and enhance the quality of life for patients, enabling them to live more independent and fulfilling lives.

ivi.ru Media Ltd. operates an online video and cinema platform in Russia, providing a wide range of content that includes movies, television series, shows, cartoons, and music videos. Founded in 2007 and based in Moscow, the platform offers a video-on-demand service that enhances the traditional television experience by allowing users to access content through a secure, scalable, and portable online player. ivi creates opportunities for both independent content producers and mainstream broadcasters by enabling live streaming channels and expanding audience reach. The company focuses on delivering licensed professional content, allowing users to enjoy premium video offerings at no cost.

TARIS Biomedical, Inc. is a therapeutically focused urology company based in Lexington, Massachusetts, established in 2008. The company specializes in developing innovative treatments for challenging bladder diseases, including bladder cancer and overactive bladder. TARIS's unique drug delivery system allows for the continuous release of medications within the bladder over extended periods, ranging from weeks to months. This system is designed to be deployed and retrieved through minimally invasive, in-office procedures, enabling a tailored approach to drug release that meets the specific needs of various bladder conditions. As of December 2019, TARIS Biomedical operates as a subsidiary of Janssen Research & Development, LLC.

OncoTartis, Inc. is a private biotechnology company founded in 2011 and based in Buffalo, New York. The company focuses on developing TARTIS technology to identify compounds that target specific cancers, including breast, prostate, ovarian cancers, melanoma, and hematological malignancies. Its innovative approach involves creating anti-cancer drugs aimed at tissue-specific targets, which are designed to minimize impact on essential bodily functions. One of its leading products, OT-82, is a nicotinamide phosphoribosyltransferase (NAMPT) inhibitor under development for the treatment of Acute Myeloid Leukemia (AML). Through its novel drug development strategy, OncoTartis aims to provide patients with new therapeutic options for treating various malignancies.

StoreDot Ltd. is an innovative battery developer based in Ramat-Gan, Israel, founded in 2012. The company specializes in creating extreme-fast charging (XFC) batteries for electric vehicles and other applications. Its technology utilizes proprietary nano-materials combined with organic and inorganic compounds to enhance electro-chemical properties, allowing for rapid charging capabilities. StoreDot's approach is inspired by nature and aims to replace traditional materials with advanced alternatives that offer improved physical, chemical, electrical, and optical properties. The company leverages artificial intelligence algorithms to optimize battery performance, catering to the growing demands of electric vehicles and mobile devices. With a strong team of scientists and engineering experts, StoreDot is positioned to lead advancements in battery technology and materials innovation across various industries.

Avelas Biosciences is focused on enhancing cancer surgery through innovative intraoperative imaging technology. The company's proprietary platform employs activatable cell-penetrating peptides to facilitate real-time diagnosis of metastatic nodes during surgical procedures. This advancement allows oncologic surgeons to create a luminous map of the surgical site, which helps in identifying critical areas and improving surgical precision. By providing this real-time information, Avelas aims to reduce the likelihood of repeat surgeries and ultimately improve patient outcomes, setting a new standard of care in the field of oncology.

DreaMed Diabetes, Ltd. is a medical device and software-as-a-service company focused on diabetes treatment and management. Founded in 2014 and based in Israel, the company is known for its innovative solutions, including Glucositter, a closed-loop insulin delivery system that monitors glucose levels in real-time and adjusts insulin delivery accordingly. DreaMed Diabetes has made significant advancements in decision support tools for diabetes management and was the first company to receive FDA clearance for a decision support system that utilizes data from continuous glucose monitors and insulin pumps. Its Advisor Pro software, developed by diabetes professionals, leverages artificial intelligence to enable healthcare providers to quickly analyze patient data and determine optimal treatment plans. This system aims to improve patient outcomes by facilitating frequent titration changes and enhancing online monitoring, ultimately helping to lower A1C levels and reduce the risk of complications. DreaMed Diabetes emphasizes patient-centered care, ensuring that all individuals receive high-quality treatment regardless of their circumstances.

TransMedics Group Inc is a commercial-stage medical technology company focused on transforming organ transplant therapy for patients with end-stage organ failure. The company has developed the Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system designed to replicate near-physiologic conditions for donor organs outside the human body. This innovative system addresses the limitations associated with traditional cold storage organ preservation, enhancing clinical outcomes and increasing transplant volumes. By providing advanced technology and clinical service solutions, TransMedics aims to improve the overall effectiveness of heart and lung transplant procedures, thereby reducing learning curves for medical professionals involved in organ transplantation.

Via Transportation Inc. is a company that develops innovative public mobility solutions, focusing on on-demand and pre-scheduled transit. Founded in 2012 and headquartered in New York, Via serves a diverse range of clients, including public transit agencies, cities, universities, corporations, and school districts. The company's mobile app connects passengers traveling in the same direction, allowing them to share premium vehicles and enhancing the efficiency of public transit systems. Via aims to transform traditional, rigid transit systems into dynamic networks by integrating its technology with existing public transportation infrastructure. This approach not only reduces operational costs and traffic congestion but also minimizes single-occupancy trips and carbon emissions, providing more accessible and environmentally friendly transit options. Via operates both in the United States and Europe through partnerships, including a joint venture with Mercedes-Benz Vans.

GiveVision develops innovative software for smart glasses aimed at aiding individuals who are blind or partially sighted. Their technology functions as an intelligent companion, capable of recognizing text, people, places, and objects, and delivering pertinent information to users on demand. This enhances mobility and independence for users. Additionally, the company creates a wearable vision aid device that leverages augmented and virtual reality technology to assist those with severe sight impairments. This device is designed to restore vision for patients with untreatable sight loss, allowing them to see both up close and at a distance, thereby significantly improving their quality of life.

Gastric Electrical Stimulation (GES) has been formally proven as one of the possible alternatives for the treatment of obesity: There are several companies nowadays who use the GES technology for the treatment of obesity; however, these companies use an implantable devices, which are expensive, invasive and may cause medical complications in the future.Melcap’s innovative system is a non-invasive low cost device, yet it uses the same GES technology for its treatment.

Kidoz is a content discovery platform dedicated to providing a safe and engaging digital environment for children aged 1 to 10. Designed to help kids easily access entertaining and relevant content, Kidoz offers a user-friendly interface that allows young users to play games and watch videos without needing to read or write. The platform reaches over 100 million children globally and supports both Kidoz-generated and parent-generated content in over 160 languages. It features a password-protected Control Panel that enables parents to personalize content based on their child's age, language, and gender, while also allowing them to add or block content as needed. Kidoz ensures that all content is moderated and pre-approved before being made available to users. This approach not only safeguards children's online experiences but also enables child-focused brands and developers to effectively monetize and distribute their content.

Driveway is a cloud-based technology that helps ordinary drivers become safe drivers and helps insurers find and reward them. The company provides auto insurers with comprehensive insured driving data for better pricing intelligence – maximizing the opportunity for lower loss ratios and higher profits. While the technology sets new performance standards in the Usage-Based Insurance arena, affordability, scalability, and ease of rollout are the head-turning features that position auto insurers for cost-effective speed to market. Driveway's patented artificial intelligence (AI) technology measures safe and unsafe driving behaviors automatically, right from a driver's smartphone. It combines sensor fusion, machine learning, and artificial intelligence algorithms to sense car trips and driver aggressiveness without the need for plug-in hardware.

AnyClip, LLC is a technology company that specializes in video management and artificial intelligence. Founded in 2007 and headquartered in New York, with additional offices in Los Angeles and Jerusalem, AnyClip provides a platform that enables users to search, view, and share clips from feature films across various genres. The company utilizes proprietary Visual Intelligence™ Technology, which extracts and indexes metadata from videos, allowing for efficient searching of specific moments within films. This technology transforms traditional video assets into intelligent content, facilitating improved internal communication and collaboration. AnyClip’s platform also offers analytics and insights, helping businesses understand viewer engagement. The company has received significant investment and recognition, ranking among the fastest-growing companies in North America.

MobiliBuy is an Israeli company that operates an innovative online platform allowing users to shop directly from advertisements displayed on boards and digital screens by scanning codes. The platform transforms any media, whether digital or print, into a virtual storefront, enabling retailers and businesses to establish virtual stores with minimal investment. MobiliBuy facilitates convenient shopping through a tailored mobile app that incorporates image and voice recognition tools, allowing users to quickly purchase products and services with just one click. This streamlined approach brings shopping directly to consumers, enhancing accessibility and convenience.

Safer Place develops an innovative, award-winning video-based technology platform to enhance traffic and parking violation enforcement. Their unified solution detects high-risk dangerous driving violations and is backed by a complete suite of applications and expert professional services.

Medviser is a marketplace dedicated to telemedicine services, facilitating direct connections between doctors and patients. The platform enables remote video consultations, primarily focusing on the Russian Federation and the Commonwealth of Independent States, with aspirations to expand into a global marketplace. By leveraging cloud technology, Medviser aims to provide patients access to top international medical professionals, enhancing the delivery of healthcare services across borders.

Via Transportation Inc. is a company that develops innovative public mobility solutions, focusing on on-demand and pre-scheduled transit. Founded in 2012 and headquartered in New York, Via serves a diverse range of clients, including public transit agencies, cities, universities, corporations, and school districts. The company's mobile app connects passengers traveling in the same direction, allowing them to share premium vehicles and enhancing the efficiency of public transit systems. Via aims to transform traditional, rigid transit systems into dynamic networks by integrating its technology with existing public transportation infrastructure. This approach not only reduces operational costs and traffic congestion but also minimizes single-occupancy trips and carbon emissions, providing more accessible and environmentally friendly transit options. Via operates both in the United States and Europe through partnerships, including a joint venture with Mercedes-Benz Vans.

Shellanoo Group is a technology company specializing in mobile applications, Internet related services and interactive artificial intelligence with cognitive solutions. Introducing a modern way to invest in technology. Shellanoo Group offers investors the range of a diversified IT portfolio with the simplicity of investing in a single company. Shellanoo Group builds, operates and manages products and services that challenge the status quo, all of which are wholly owned by the Company. Founded in mid-2014 in Israel, Shellanoo Group has grown into one of Israel’s more appealing technology firms, combining both business expertise and technological strength.

AcousticEye B.V., founded in 2005 and based in Leusden, the Netherlands, specializes in tube inspection solutions for the heat exchanger market. The company develops and markets advanced mobile and embedded tube inspection devices utilizing patented acoustic technology. Its flagship product, the Dolphin Tube Inspection Solution, is an integrated non-destructive testing (NDT) system designed to inspect and monitor heat exchanger tubes efficiently. AcousticEye's technology enables rapid and accurate single-point inspections of inaccessible tubes, allowing for the quick identification and precise location of defects in complex tube systems, regardless of material. The company serves various industries, including oil and gas, power generation, chemicals, food and beverage, pulp and paper, HVAC, and petrochemicals.

Weedingtech are the manufacturers of Foamstream, the award winning, herbicide-free system of controlling weeds, offering the most effective alternative to traditional chemical herbicides. Available for the first time on a commercial basis to the amenity and water industries, it kills weeds using a precise application of hot water and foam. Discover how your organisation could benefit from this exciting new technology today.

Truphone Limited is a mobile telecommunications company that offers a range of services designed to enhance global connectivity for enterprises and consumers. Its key offerings include Truphone SIM, which allows users to manage multiple international numbers through a single SIM card, and Truphone Mobile Recording, which provides secure recording, encryption, and storage of calls and SMS messages across borders. The Truphone App facilitates calls and messaging between users over Wi-Fi and mobile networks. The company also supports eSIM-enabled devices, allowing other mobile operators to quickly implement this technology. Founded in 2000 and headquartered in London, Truphone has expanded its presence internationally with offices in various countries, serving a diverse clientele, from large corporations to individual users.